Serum thyroglobulin, a monitor of differentiated thyroid carcinoma in patients receiving thyroid hormone suppression therapy: concise communication

Journal Article · Fri Jun 01 00:00:00 EDT 1984 · J. Nucl. Med.; (United States)

OSTI ID:6682866

Blahd, W H; Drickman, M V; Porter, C W; Hill, V A; Baumgartner, W A

Serum thyroglobulin levels were obtained in 86 patients who had undergone thyroidectomy and I-131 ablation for differentiated thyroid cancer, and who were receiving or had recently discontinued thyroid hormone suppression therapy. Excellent correlation was observed between serum thyroglobulin levels in patients receiving thyroid hormone suppression therapy and I-131 imaging studies. Serum thyroglobulin levels equal to or below 20 ng/ml indicate the absence of thyroid carcinoma, and values exceeding 60 ng/ml were indicative of active thyroid cancer but may include some patients without clinical evidence of disease. Intermediate serum thyroglobulin levels were observed in a small number of patients with post-surgical thyroid remnants or active disease.

• Research Organization: Univ. of California, Los Angeles
• OSTI ID: 6682866
• Journal Information: J. Nucl. Med.; (United States), Vol. 25:6
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
IODINE 131
SCINTISCANNING
RADIOTHERAPY
EVALUATION
THYROGLOBULIN
BLOOD CHEMISTRY
RADIOIMMUNOASSAY
THYROID
CARCINOMAS
IMMUNOSUPPRESSION
PATIENTS
THYROIDECTOMY
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
COUNTING TECHNIQUES
DAYS LIVING RADIOISOTOPES
DIAGNOSTIC TECHNIQUES
DISEASES
ENDOCRINE GLANDS
GLANDS
GLOBULINS
INTERMEDIATE MASS NUCLEI
IODINE ISOTOPES
ISOTOPE APPLICATIONS
ISOTOPES
MEDICINE
NEOPLASMS
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
ORGANIC COMPOUNDS
ORGANS
PROTEINS
RADIOASSAY
RADIOISOTOPE SCANNING
RADIOISOTOPES
RADIOLOGY
SURGERY
THERAPY
TRACER TECHNIQUES
550601* - Medicine- Unsealed Radionuclides in Diagnostics
550604 - Medicine- Unsealed Radionuclides in Therapy- (1980-)